Tumor microenvironment-based screening repurposes drugs targeting cancer stem cells and cancer-associated fibroblasts.

The tumorous niche may drive the plasticity of heterogeneity and cancer stemness, leading to drug resistance and metastasis, which is the main reason of treatment failure in most cancer patients. The aim of this study was to establish a tumor microenvironment (TME)-based screening to identify drugs that can specifically target cancer stem cells (CSCs) and cancer-associated fibroblasts (CAFs) in the TME. Methods: Lung cancer patient-derived cancer cell and CAFs were utilized to mimic the TME and reproduce the stemness properties of CSCs in vitro and develop a high-throughput drug screening platform with phenotypical parameters. Limiting dilution assay, sphere-forming and ALDH activity assay were utilized to measure the cancer stemness characteristics. In vivo patient-derived xenograft (PDX) models and single-cell RNA sequencing were used to evaluate the mechanisms of the compounds in CSCs and CAFs. Results: The TME-based drug screening platform could comprehensively evaluate the response of cancer cells, CSCs and CAFs to different treatments. Among the 1,524 compounds tested, several drugs were identified to have anti-CAFs, anticancer and anti-CSCs activities. Aloe-emodin and digoxin both show anticancer and anti-CSCs activity in vitro and in vivo, which was further confirmed in the lung cancer PDX model. The combination of digoxin and chemotherapy improved therapeutic efficacy. The single-cell transcriptomics analysis revealed that digoxin could suppress the CSCs subpopulation in CAFs-cocultured cancer cells and cytokine production in CAFs. Conclusions: The TME-based drug screening platform provides a tool to identify and repurpose compounds targeting cancer cells, CSCs and CAFs, which may accelerate drug development and therapeutic application for lung cancer patients.

Suspension survival mediated by PP2A-STAT3-Col XVII determines tumour initiation and metastasis in cancer stem cells.

Targeting tumour-initiating cells (TICs) would lead to new therapies to cure cancer. We previously demonstrated that TICs have the capacity to survive under suspension conditions, while other cells undergo anoikis. Here we show that TICs exhibit increased phosphorylation levels of S727STAT3 because of PP2A inactivation. Collagen 17 gene expression is upregulated in a STAT3-dependent manner, which also stabilizes laminin 5 and engages cells to form hemidesmosome-like junctions in response. Blocking the PP2A-S727STAT3-collagen 17 pathway inhibits the suspension survival of TICs and their ability to form tumours in mice, while activation of the same pathway increases the suspension survival and tumour-initiation capacities of bulk cancer cells. The S727STAT3 phosphorylation levels correlate with collagen 17 expression in colon tumour samples, and correlate inversely with survival. Finally, this signalling axis enhances the ability of TIC to form tumours in mouse models of malignant lung cancer pleural effusion and spontaneous colon cancer metastasis.

Analysis of aqueous pyrethroid residuals by one-step microwave-assisted headspace solid-phase microextraction and gas chromatography with electron capture detection.

A one-step microwave-assisted headspace solid-phase microextraction (MA-HS-SPME) has been applied to be a pretreatment step in the analysis of aqueous pyrethroid residuals by gas chromatography (GC) with electron capture detection (ECD). Microwave heating was applied to accelerate the vaporization of pyrethroids (bioallenthrin, bifenthrin, fenpropathrin, cyhalothrin, permethrin, cyfluthrin, cypermethrin, fluvalinate, fenvalerate and deltamethrin) into the headspace, and then being absorbed directly on a SPME fiber under the controlled conditions. Optimal conditions for the SPME sampling, such as the selection of sampling fiber, sample pH, sampling temperature and time, microwave irradiation power, desorption temperature and time were investigated and then applied to real sample analysis. Experimental results indicated that the extraction of pyrethroids from a 20-mL aquatic sample (pH 4.0) was achieved with the best efficiency through the use of a 100-microm PDMS fiber, microwave irradiation of 157 W and sampling at 30 degrees C for 10 min. Under optimum conditions, the detections were linear in the range of 0.05-0.5 microg/L with the square of correlation coefficients (R(2)) of >0.9913 for pyrethroids except bifenthrin being 0.9812. Method detection limits (MDL) were found to be varied from 0.2 to 2.6 ng/L for different pyrethroids based on S/N (signal to noise)=3. The coefficients of variation (CVs) for repeatability were 7-21%. A field underground water sample was analyzed with recovery between 88.5% to 115.5%. This method was proven to be a very simple, rapid, and solvent-free process to achieve the sample pretreatment before the analysis of trace pyrethroids in aqueous samples by gas chromatography.